Sensorygen uses machine learning and computational neurobiology to discover natural compounds with improved efficacy, safety, and sensorial properties for everyday products. Its core product is a patented, all‑natural, broad‑spectrum insect repellent that independent lab tests report provides nearly double the protection time of DEET, is non‑toxic, does not damage synthetic fabrics or plastics, and is pleasant to smell. The company’s technology and compound library are exclusively licensed from UC Riverside and are rooted in work from founder Dr. Anandasankar Ray’s laboratory. Sensorygen intends to use its platform to pursue opportunities beyond topical repellents, including agricultural repellents, sweet enhancers, and flavor/fragrance and nutraceutical applications. The company is led by CEO Thomas Stone and is pursuing U.S. EPA regulatory approval for its insect repellent. In March 2021 Sensorygen closed $1.5M in equity financing to complete final‑phase testing and advance regulatory approval.

Total raised

$2M

Funding rounds

1

Latest round

Equity

Latest activity

Mar 2021